DexCom, Inc. (DXCM)
NASDAQ: DXCM · Real-Time Price · USD
67.78
+1.75 (2.65%)
Oct 8, 2025, 4:00 PM EDT - Market closed
DexCom Stock Forecast
Stock Price Forecast
The 19 analysts that cover DexCom stock have a consensus rating of "Strong Buy" and an average price target of $97.42, which forecasts a 43.73% increase in the stock price over the next year. The lowest target is $85 and the highest is $115.
Price Target: $97.42 (+43.73%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DexCom stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
---|---|---|---|---|---|---|
Strong Buy | 8 | 9 | 8 | 9 | 8 | 8 |
Buy | 8 | 8 | 8 | 8 | 8 | 8 |
Hold | 3 | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 19 | 20 | 19 | 20 | 19 | 19 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Strong Buy Maintains $105 → $85 | Strong Buy | Maintains | $105 → $85 | +25.41% | Oct 7, 2025 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $104 → $89 | Strong Buy | Maintains | $104 → $89 | +31.31% | Oct 1, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $106 | Strong Buy | Maintains | $106 | +56.39% | Sep 29, 2025 |
Baird | Baird | Buy Maintains $112 → $90 | Buy | Maintains | $112 → $90 | +32.78% | Sep 26, 2025 |
Argus Research | Argus Research | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +47.54% | Aug 21, 2025 |
Financial Forecast
Revenue This Year
4.72B
from 4.03B
Increased by 17.01%
Revenue Next Year
5.44B
from 4.72B
Increased by 15.36%
EPS This Year
2.09
from 1.42
Increased by 46.97%
EPS Next Year
2.63
from 2.09
Increased by 25.55%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 4.9B | 5.8B | |||
Avg | 4.7B | 5.4B | |||
Low | 4.5B | 5.0B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 22.4% | 23.8% | |||
Avg | 17.0% | 15.4% | |||
Low | 12.0% | 5.8% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 2.26 | 3.06 | |||
Avg | 2.09 | 2.63 | |||
Low | 1.87 | 2.26 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 58.6% | 46.0% | |||
Avg | 47.0% | 25.6% | |||
Low | 31.4% | 7.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.